• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗人肺表面活性物质相关蛋白A单克隆抗体的制备与鉴定

[Preparation and identification of monoclonal antibodies against human pulmonary surfactant-associated protein A].

作者信息

Liu Yong-mei, Feng Zhi-chun, Du Jiang, Wu Bing-yi, Tan Yue-er, Wang Xian-yan

机构信息

Department of Pediatrics, Zhujiang Hospital, First Military Medical University, Guangzhou 510282, China.

出版信息

Di Yi Jun Yi Da Xue Xue Bao. 2003 Aug;23(8):849-51.

PMID:12919917
Abstract

OBJECTIVE

To prepare monoclonal antibody (mAb) against human pulmonary surfactant-associated protein A (SP-A) and evaluate its specificities.

METHODS

The hybridoma cell line secreting SP-A mAb was established to induce the production of SP-A ascites fluid in BALB/c mice immunized with SP-A. The ascites fluid was then collected and purified through (NH4)2SO4 salting-out procedure, and the titer and specificity of the purified monoclonal anti-SP-A antibodies were determined by Western blotting and indirect enzyme-linked immunosorbent assay, respectively.

RESULTS

Three hybridoma cell lines capable of specific antibody secretion were established, among which 2B6 produced the antibody of the highest titer, with the hybridoma cell chromosome exceeding 100. The antibody titers in the ascitic fluid and cell supernatant fluid were 1: 50,000 and 1: 10,000 respectively, and Western blotting displayed a reaction band representing a relative molecular mass of 31,000, which was produced by the monoclonal antibody in reaction to purified SP-A.

CONCLUSION

The antibodies of high purity and specificity against human SP-A have been successfully prepared.

摘要

目的

制备抗人肺表面活性物质相关蛋白A(SP-A)的单克隆抗体(mAb)并评估其特异性。

方法

建立分泌SP-A mAb的杂交瘤细胞系,在用SP-A免疫的BALB/c小鼠中诱导产生SP-A腹水。然后收集腹水并通过硫酸铵盐析法进行纯化,分别通过蛋白质印迹法和间接酶联免疫吸附测定法测定纯化的抗SP-A单克隆抗体的效价和特异性。

结果

建立了3株能够分泌特异性抗体的杂交瘤细胞系,其中2B6产生的抗体效价最高,杂交瘤细胞染色体超过100条。腹水中和细胞上清液中的抗体效价分别为1:50000和1:10000,蛋白质印迹显示出一条代表相对分子质量为31000的反应带,这是单克隆抗体与纯化的SP-A反应产生的。

结论

已成功制备出针对人SP-A的高纯度、特异性抗体。

相似文献

1
[Preparation and identification of monoclonal antibodies against human pulmonary surfactant-associated protein A].抗人肺表面活性物质相关蛋白A单克隆抗体的制备与鉴定
Di Yi Jun Yi Da Xue Xue Bao. 2003 Aug;23(8):849-51.
2
[Preparation and identification of the monoclonal antibody against human endostatin].[抗人内皮抑素单克隆抗体的制备与鉴定]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2003 Nov;19(6):580-1.
3
[Preparation and identification of monoclonal antibodies against human DcR3].抗人DcR3单克隆抗体的制备与鉴定
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2008 Feb;24(2):139-41.
4
[Preparation, characterization and preliminary application of monoclonal antibody against human mu chain].抗人μ链单克隆抗体的制备、鉴定及初步应用
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2005 May;21(3):325-7.
5
[Preparation and identification of monoclonal antibodies against Type M/N and Glycophorin A/B].[抗M/N型及血型糖蛋白A/B单克隆抗体的制备与鉴定]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2007 Jun;23(6):556-8.
6
[Preparation and characterization of monoclonal antibody against human carboxylesterases-II].[抗人羧酸酯酶-II单克隆抗体的制备与鉴定]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2007 Feb;23(2):148-51.
7
[Preparation and characterization of monoclonal antibody against DCXR].抗DCXR单克隆抗体的制备与鉴定
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2006 May;22(3):377-9.
8
[Preparation and characterization of monoclonal antibody against DR5].抗DR5单克隆抗体的制备与鉴定
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2006 Jul;22(4):514-6, 520.
9
Development of hybridoma cells producing monoclonal antibody against human epsilon (epsilon) chain.产生抗人ε链单克隆抗体的杂交瘤细胞的研制
Hum Antibodies. 2003;12(3):93-8.
10
[Preparation and identification of monoclonal antibody against enoyl-CoA hydratase 1].[抗烯酰辅酶A水合酶1单克隆抗体的制备与鉴定]
Nan Fang Yi Ke Da Xue Xue Bao. 2009 Apr;29(4):648-51.